Morgan Stanley lowers PT for PTC Therapeutics to $71 from $76.
ByAinvest
Wednesday, Aug 20, 2025 12:01 pm ET4min read
ACI--
Notable adjustments include:
- Home Depot Inc (HD): D.A. Davidson increased the price target from $450 to $475, while Bernstein raised it to $403. Jefferies and JP Morgan also made upward revisions, with Jefferies setting the target at $474 and JP Morgan at $452. Mizuho and RBC also increased their targets, with Mizuho setting it at $450 and RBC at $401. Truist Securities and Wells Fargo also made upward adjustments, with Truist Securities at $454 and Wells Fargo at $450.
- News Corp (NWS): JP Morgan increased the price target from $38 to $40.
- Premier Inc (PINC): Baird raised the price target from $22 to $27, while BofA Global Research increased it to $21. UBS also revised the target upward to $27.
- Upstart Holdings Inc (UPST): JP Morgan upgraded its recommendation from neutral to overweight.
- Vita Coco Company Inc (COCO): Piper Sandler upgraded its recommendation from neutral to overweight.
Other companies that saw changes include:
- Abercrombie & Fitch Co (ANF): Citigroup downgraded its recommendation from buy to neutral.
- Adm (ADM): JP Morgan initiated coverage with a neutral recommendation and a price target of $61.
- Affirm Holdings Inc (AFRM): JP Morgan increased the price target from $84 to $91.
- Agree Realty Corp (ADC): Barclays reduced the price target from $78 to $77.
- Albertsons Companies Inc (ACI): JP Morgan initiated coverage with an overweight recommendation and a price target of $27.
- Allstate Corp (ALL): BMO increased the price target from $230 to $235.
- Apa Corp (APA): UBS raised the price target from $21 to $23.
- AT&T Inc (T): BofA Global Research added the stock to its U.S. 1 list.
- Atmus Filtration Technologies Inc (ATMU): JP Morgan reduced the price target from $46 to $44.
- Avis Budget Group Inc (CAR): BofA Global Research reduced the price target from $120 to $113 and downgraded the recommendation from buy to underperform.
- Bath & Body Works Inc (BBWI): TD Cowen reduced the price target from $48 to $38.
- Bellring Brands (BRBR): JP Morgan initiated coverage with an overweight recommendation and a price target of $52.
- Beyond Meat Inc (BYND): JP Morgan initiated coverage with an underweight recommendation.
- Black Hills Corp (BKH): BofA Global Research increased the price target from $57 to $64 and upgraded the recommendation from underperform to neutral.
- Brown-Forman Corp (BF.A): JP Morgan increased the price target from $28 to $30.
- Bunge (BG): JP Morgan initiated coverage with an overweight recommendation and a price target of $95.
- California Resources Corp (CRC): UBS raised the price target from $61 to $63.
- Campbell's Co (CPB): JP Morgan initiated coverage with a neutral recommendation and a price target of $33.
- Celldex Therapeutics Inc (CLDX): Citigroup reduced the price target from $56 to $48, while H.C. Wainwright lowered it to $42, and Wells Fargo to $38.
- Chevron (CVX): UBS increased the price target from $186 to $197.
- Chord Energy Corp (CHRD): UBS raised the price target from $120 to $122.
- Circle Internet Group Inc (CRCL): Deutsche Bank reduced the price target from $163 to $123.
- Civitas Resources Inc (CIVI): UBS increased the price target from $30 to $38.
- Claros Mortgage Trust Inc (CMTG): UBS increased the price target from $4.5 to $4.
- Cognizant (CTSH): JP Morgan reduced the price target from $101 to $89.
- Composecure Inc (CMPO): JP Morgan downgraded the recommendation from neutral to underweight.
- Comstock Resources Inc (CRK): UBS reduced the price target from $18 to $14.
- Conagra Brands Inc (CAG): JP Morgan initiated coverage with a neutral recommendation and a price target of $20.
- ConocoPhillips (COP): UBS increased the price target from $116 to $124.
- Coupang Inc (CPNG): Morgan Stanley increased the price target from $32 to $35.
- Custom Truck One Source Inc (CTOS): JP Morgan reduced the price target from $6 to $5.50 and downgraded the recommendation from neutral to underweight.
- Darling Ingredients (DAR): JP Morgan initiated coverage with an overweight recommendation and a price target of $43.
- Devon Energy Corp (DVN): UBS increased the price target from $37 to $40.
- Diamondback Energy Inc (FANG): Raymond James reduced the price target from $221 to $212, while UBS increased it to $171.
- Digital Realty Trust Inc (DLR): Barclays increased the price target from $140 to $141.
- Digitalbridge Group Inc (DBRG): Truist Securities increased the price target from $15 to $16.
- Dollar Tree Inc (DLTR): Citigroup increased the price target from $103 to $130.
- DXC Technology Co (DXC): JP Morgan reduced the price target from $18 to $14.
- Edwards Lifesciences Corp (EW): Leerink Partners increased the price target from $84 to $85.
- EOG Resources Inc (EOG): UBS increased the price target from $142 to $144.
- Epam Systems Inc (EPAM): JP Morgan reduced the price target from $205 to $201.
- EQT Corp (EQT): UBS increased the price target from $64 to $65.
- Equinix Inc (EQIX): Barclays increased the price target from $798 to $804.
- Etsy Inc (ETSY): Truist Securities increased the price target from $70 to $75.
- Evgo Inc (EVGO): UBS increased the price target from $5.4 to $5.
- Exlservice Holdings Inc (EXLS): JP Morgan reduced the price target from $56 to $52.
- Expand Energy Corp (EXE): UBS reduced the price target from $145 to $132.
- Exxon Mobil Corp (XOM): UBS increased the price target from $130 to $143.
- Federal Realty Investment Trust (FRT): Mizuho increased the price target from $96 to $100.
- Four Corners Property Trust Inc (FCPT): Barclays reduced the price target from $30 to $29.
- Freshpet Inc (FRPT): JP Morgan initiated coverage with a neutral recommendation and a price target of $70.
- Ftai Aviation Ltd (FTAI): Morgan Stanley increased the price target from $138 to $175.
- Gaming & Leisure Properties Inc (GLPI): Barclays reduced the price target from $55 to $51.
- Gap Inc (GAP): Citigroup downgraded the recommendation from buy to neutral and reduced the price target from $30 to $22.
- General Mills (GIS): JP Morgan initiated coverage with a subponderation recommendation and a price target of $45.
- Gilead (GILD): Bernstein increased the price target from $120 to $135.
- Goodyear Tire & Rubber Co (GT): HSBC reduced the price target from $15.5 to $9.5 and downgraded the recommendation from buy to hold.
- Granite Point Mortgage Trust Inc (GPMT): UBS increased the price target from $3.25 to $3.5.
- Greenwich Lifesciences (GLSI): Noble Capital initiated coverage with an outperform recommendation and a price target of $45.
- Grid Dynamics Holdings Inc (GDYN): JP Morgan reduced the price target from $13 to $11.
- Gulfport Energy Corp (GPOR): UBS reduced the price target from $240 to $227.
- Halliburton Co (
ADC--
ADM--
AFRM--
ALL--
Morgan Stanley lowers PT for PTC Therapeutics to $71 from $76.
In a recent wave of updates, analysts from various firms have revised their price targets and recommendations for several U.S.-listed companies. The changes, reported by Reuters on July 2, 2025, reflect a mix of upward and downward revisions, indicating a shift in market sentiment and expectations.Notable adjustments include:
- Home Depot Inc (HD): D.A. Davidson increased the price target from $450 to $475, while Bernstein raised it to $403. Jefferies and JP Morgan also made upward revisions, with Jefferies setting the target at $474 and JP Morgan at $452. Mizuho and RBC also increased their targets, with Mizuho setting it at $450 and RBC at $401. Truist Securities and Wells Fargo also made upward adjustments, with Truist Securities at $454 and Wells Fargo at $450.
- News Corp (NWS): JP Morgan increased the price target from $38 to $40.
- Premier Inc (PINC): Baird raised the price target from $22 to $27, while BofA Global Research increased it to $21. UBS also revised the target upward to $27.
- Upstart Holdings Inc (UPST): JP Morgan upgraded its recommendation from neutral to overweight.
- Vita Coco Company Inc (COCO): Piper Sandler upgraded its recommendation from neutral to overweight.
Other companies that saw changes include:
- Abercrombie & Fitch Co (ANF): Citigroup downgraded its recommendation from buy to neutral.
- Adm (ADM): JP Morgan initiated coverage with a neutral recommendation and a price target of $61.
- Affirm Holdings Inc (AFRM): JP Morgan increased the price target from $84 to $91.
- Agree Realty Corp (ADC): Barclays reduced the price target from $78 to $77.
- Albertsons Companies Inc (ACI): JP Morgan initiated coverage with an overweight recommendation and a price target of $27.
- Allstate Corp (ALL): BMO increased the price target from $230 to $235.
- Apa Corp (APA): UBS raised the price target from $21 to $23.
- AT&T Inc (T): BofA Global Research added the stock to its U.S. 1 list.
- Atmus Filtration Technologies Inc (ATMU): JP Morgan reduced the price target from $46 to $44.
- Avis Budget Group Inc (CAR): BofA Global Research reduced the price target from $120 to $113 and downgraded the recommendation from buy to underperform.
- Bath & Body Works Inc (BBWI): TD Cowen reduced the price target from $48 to $38.
- Bellring Brands (BRBR): JP Morgan initiated coverage with an overweight recommendation and a price target of $52.
- Beyond Meat Inc (BYND): JP Morgan initiated coverage with an underweight recommendation.
- Black Hills Corp (BKH): BofA Global Research increased the price target from $57 to $64 and upgraded the recommendation from underperform to neutral.
- Brown-Forman Corp (BF.A): JP Morgan increased the price target from $28 to $30.
- Bunge (BG): JP Morgan initiated coverage with an overweight recommendation and a price target of $95.
- California Resources Corp (CRC): UBS raised the price target from $61 to $63.
- Campbell's Co (CPB): JP Morgan initiated coverage with a neutral recommendation and a price target of $33.
- Celldex Therapeutics Inc (CLDX): Citigroup reduced the price target from $56 to $48, while H.C. Wainwright lowered it to $42, and Wells Fargo to $38.
- Chevron (CVX): UBS increased the price target from $186 to $197.
- Chord Energy Corp (CHRD): UBS raised the price target from $120 to $122.
- Circle Internet Group Inc (CRCL): Deutsche Bank reduced the price target from $163 to $123.
- Civitas Resources Inc (CIVI): UBS increased the price target from $30 to $38.
- Claros Mortgage Trust Inc (CMTG): UBS increased the price target from $4.5 to $4.
- Cognizant (CTSH): JP Morgan reduced the price target from $101 to $89.
- Composecure Inc (CMPO): JP Morgan downgraded the recommendation from neutral to underweight.
- Comstock Resources Inc (CRK): UBS reduced the price target from $18 to $14.
- Conagra Brands Inc (CAG): JP Morgan initiated coverage with a neutral recommendation and a price target of $20.
- ConocoPhillips (COP): UBS increased the price target from $116 to $124.
- Coupang Inc (CPNG): Morgan Stanley increased the price target from $32 to $35.
- Custom Truck One Source Inc (CTOS): JP Morgan reduced the price target from $6 to $5.50 and downgraded the recommendation from neutral to underweight.
- Darling Ingredients (DAR): JP Morgan initiated coverage with an overweight recommendation and a price target of $43.
- Devon Energy Corp (DVN): UBS increased the price target from $37 to $40.
- Diamondback Energy Inc (FANG): Raymond James reduced the price target from $221 to $212, while UBS increased it to $171.
- Digital Realty Trust Inc (DLR): Barclays increased the price target from $140 to $141.
- Digitalbridge Group Inc (DBRG): Truist Securities increased the price target from $15 to $16.
- Dollar Tree Inc (DLTR): Citigroup increased the price target from $103 to $130.
- DXC Technology Co (DXC): JP Morgan reduced the price target from $18 to $14.
- Edwards Lifesciences Corp (EW): Leerink Partners increased the price target from $84 to $85.
- EOG Resources Inc (EOG): UBS increased the price target from $142 to $144.
- Epam Systems Inc (EPAM): JP Morgan reduced the price target from $205 to $201.
- EQT Corp (EQT): UBS increased the price target from $64 to $65.
- Equinix Inc (EQIX): Barclays increased the price target from $798 to $804.
- Etsy Inc (ETSY): Truist Securities increased the price target from $70 to $75.
- Evgo Inc (EVGO): UBS increased the price target from $5.4 to $5.
- Exlservice Holdings Inc (EXLS): JP Morgan reduced the price target from $56 to $52.
- Expand Energy Corp (EXE): UBS reduced the price target from $145 to $132.
- Exxon Mobil Corp (XOM): UBS increased the price target from $130 to $143.
- Federal Realty Investment Trust (FRT): Mizuho increased the price target from $96 to $100.
- Four Corners Property Trust Inc (FCPT): Barclays reduced the price target from $30 to $29.
- Freshpet Inc (FRPT): JP Morgan initiated coverage with a neutral recommendation and a price target of $70.
- Ftai Aviation Ltd (FTAI): Morgan Stanley increased the price target from $138 to $175.
- Gaming & Leisure Properties Inc (GLPI): Barclays reduced the price target from $55 to $51.
- Gap Inc (GAP): Citigroup downgraded the recommendation from buy to neutral and reduced the price target from $30 to $22.
- General Mills (GIS): JP Morgan initiated coverage with a subponderation recommendation and a price target of $45.
- Gilead (GILD): Bernstein increased the price target from $120 to $135.
- Goodyear Tire & Rubber Co (GT): HSBC reduced the price target from $15.5 to $9.5 and downgraded the recommendation from buy to hold.
- Granite Point Mortgage Trust Inc (GPMT): UBS increased the price target from $3.25 to $3.5.
- Greenwich Lifesciences (GLSI): Noble Capital initiated coverage with an outperform recommendation and a price target of $45.
- Grid Dynamics Holdings Inc (GDYN): JP Morgan reduced the price target from $13 to $11.
- Gulfport Energy Corp (GPOR): UBS reduced the price target from $240 to $227.
- Halliburton Co (

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet